Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice.
Orexins are neuropeptides that have a wide range of physiological effects, and recent studies have suggested that the orexin system may be involved in traumatic brain injury. However, the expression and localization of orexin receptors have not been examined yet under brain injury conditions. In the present study, we used immunohistochemical techniques to investigate the expression of orexin-1 receptor (OX1R) and its time-dependent changes in the mouse brain after controlled cortical impact (CCI) injury. OX1R-like immunoreactivity was first detected 6 h after injury in the surrounding penumbra of the injury. The intensity of this immunoreactivity was increased at 12 h, peaked at day 1, and then decreased from day 2 to day 7. To identify the cellular localization of OX1R, we also performed double-immunohistochemical staining with OX1R and several cell marker antibodies. OX1R-like immunopositive cells were clearly co-localized with immunoreactivity for the neuronal marker NeuN at day 7. It was also expressed on the periphery of cells immunopositive for CD11b, a microglial cell marker, at days 1 and 7. These results suggest that orexin and its receptor may play roles in traumatic brain injury, and that OX1R is induced in neurons and microglial cells after traumatic brain injury.
Mihara
Yuko
Y
Department of Emergency and Critical Care Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan.
Dohi
Kenji
K
Yofu
Sachiko
S
Nakamachi
Tomoya
T
Ohtaki
Hirokazu
H
Shioda
Seiji
S
Aruga
Tohru
T
D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000378:metabolism; D001930:Brain Injuries / Q000378:metabolism* / Q000473:pathology; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000166:cytology / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D009479:Neuropeptides / Q000378:metabolism; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D018013:Receptors, Neuropeptide / Q000378:metabolism*
D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D064446:Orexin Receptors; D000068797:Orexins; D043562:Receptors, G-Protein-Coupled; D018013:Receptors, Neuropeptide
Neurology. 2001 Dec 26;57(12):2253-8
11756606
Sleep Med Rev. 2005 Aug;9(4):269-310
16006155
Lancet. 2000 Jan 1;355(9197):39-40
10615891
Prog Neurobiol. 2008 Mar;84(3):211-33
18262323
J Neurosci. 1998 Aug 1;18(15):5663-72
9671657
J Pharmacol Exp Ther. 2003 Jan;304(1):1-7
12490568
Brain. 2007 Jul;130(Pt 7):1873-83
17584779
Regul Pept. 2005 Mar 15;126(1-2):49-54
15620413
Ann Neurol. 2009 Oct;66(4):555-9
19847903
Peptides. 2005 Nov;26(11):2339-43
15893406
J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1667-73
14638887
Nat Med. 2000 Sep;6(9):991-7
10973318
Neurosci Lett. 2002 May 10;324(1):53-6
11983293
Neuron. 2000 Sep;27(3):469-74
11055430
Trends Neurosci. 1996 Aug;19(8):312-8
8843599
J Biol Chem. 2004 Oct 29;279(44):45875-86
15310763
Neurology. 2005 Jul 12;65(1):147-9
16009905
Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):322-7
9419374
Biochem Biophys Res Commun. 2000 Apr 2;270(1):318-23
10733946
Nat Rev Neurosci. 2007 Jan;8(1):57-69
17180163
J Neurosci Methods. 1991 Oct;39(3):253-62
1787745
Biochem Biophys Res Commun. 2002 Aug 9;296(1):129-33
12147238
J Neurosurg. 1999 Oct;91(4):653-9
10507388
J Comp Neurol. 2001 Jun 18;435(1):6-25
11370008
PLoS One. 2010 Jan 06;5(1):e8587
20062799
Neurosurgery. 1998 Mar;42(3):555-72; discussion 573-4
9526991
Neuroscience. 2001;103(3):777-97
11274794
Endocrinology. 2006 Oct;147(10):4977-84
16857748
Neurology. 2003 Aug 26;61(4):540-3
12939433
Neurosci Lett. 2002 May 10;324(1):5-8
11983281
Neuropeptides. 2006 Aug;40(4):245-50
16930690